Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)?

Louis-Marie Galerneau (Grenoble, France), Louis-Marie Galerneau, Jean-Louis Pépin, Anne-Laure Borel, Olivier Chabre, Marc Sapene, Bruno Stach, Janie Girey-Rannaud, Renaud Tamisier, Philippe Caron

Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Louis-Marie Galerneau (Grenoble, France), Louis-Marie Galerneau, Jean-Louis Pépin, Anne-Laure Borel, Olivier Chabre, Marc Sapene, Bruno Stach, Janie Girey-Rannaud, Renaud Tamisier, Philippe Caron. Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)?. Eur Respir J 2016; 48: Suppl. 60, 1802

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity?
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016


Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015


Differences in prevalence of metabolic syndrome (MS) between male and female patients with moderate and severe obstructive sleep apnea. The definition is certainly an important factor
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014

Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016


Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities?
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain)
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


The effects of obstructive sleep apnea on cardiovascular functioning in children with obesity
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013

The investigation of relationship between red cell distribution width and cardiovascular diseases in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Evaluation of lipid profile in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015


Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


Prevalence of obesity hypoventilation syndrome in OSA patients in the UAE
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Obstructive sleep apnea syndrome and cardiometabolic disorders – Is there an association?
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015

Prevalence and diagnosis of obesity hypoventilation syndrome (OHS) in ambulatory obese patients
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016


Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA)
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015

Prevalence of metabolic syndrome (MS) in a population of apneic patients:A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


Obstructive sleep apnoea syndrome and a calculation of cardiovascular risk
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014